AR-A014418, an ATP-competitive and selective GSK-3β inhibitor, has been reported to suppress the proliferation and induce the apoptosis of gastric cancer [36], synovial sarcoma, and fibrosarcoma cells in vitro as well as in vivo [37]. The gene discussed is GSK3B; the disease is gastric cancer.